Evidence map›Paper›PMID 42806489›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Gut Microbial Topology and Metabolic Signatures Associated With Colorectal Neoplasia.

Kai Song, Youwen Qin, Jiahui Luo, Liping Liu, Chenyu Luo, Yinbin Qiu, Yiyi Zhong, Huanzi Zhong, Kui Wu, Meng Ni and 4 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kai Song *Center for Prevention and Early Intervention, National Infrastructures for Translational Medicine, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID https://orcid.org/0000-0003-4459-7059
Youwen Qin *Shenzhen Hospital, Southern Medical University, Shenzhen, China.ORCID https://orcid.org/0000-0003-3956-4711
Jiahui Luo *Center for Prevention and Early Intervention, National Infrastructures for Translational Medicine, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID https://orcid.org/0009-0006-7800-2577
Liping Liu *BGI Genomics, Shenzhen, China.
Chenyu LuoCenter for Prevention and Early Intervention, National Infrastructures for Translational Medicine, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID https://orcid.org/0000-0001-8147-9540
Yinbin QiuBGI Genomics, Shenzhen, China.ORCID https://orcid.org/0000-0002-5361-4781
Yiyi ZhongBGI Precision Nutrition (Shenzhen) Technology Co., Ltd, Shenzhen, China.
Huanzi ZhongBGI Genomics, Shenzhen, China.
Kui WuBGI Genomics, Shenzhen, China.ORCID https://orcid.org/0000-0002-6857-7231
Meng NiBGI Genomics, Shenzhen, China.
Dong WuDepartment of Gastroenterology & Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID https://orcid.org/0000-0001-9430-9874
Min DaiDepartment of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Shida ZhuBGI Genomics, Shenzhen, China.
Hongda ChenCenter for Prevention and Early Intervention, National Infrastructures for Translational Medicine, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID https://orcid.org/0000-0001-6171-1162

Funding

Beijing Research Ward Excellence Program BRWEP2024W034010101CAMS Innovation Fund for Medical Sciences 2022-I2M-1-003National High Level Hospital Clinical Research 2025-LYZX-C-B03National High Level Hospital Clinical Research 2025-PUMCH-C-048National Key Research and Development Project of China 2024YFA0918500National Natural Science Foundation of China 82273726National Natural Science Foundation of China 82473705National Science and Technology Major Program of China 2025ZD0551704PUMCH Talent Development Program (Category B Project) UGG06641Science and Technology Projects of Xizang Autonomous Region, China XZ202501JD0021
6 · The paper itself

Abstract

Alterations of gut microbial communities impact health. However, the structure and function of community-level topologies related to colorectal neoplasia (CRN) remain unclear. We analyzed 3807 newly sequenced stool metagenomes from participants (2725 healthy controls, 759 non-advanced adenomas, 297 advanced adenomas, and 26 colorectal cancers) in a multicenter TARGET-C screening trial and validated our findings in multiple independent cohorts. We identified a CRN-associated network (14 species, including Clostridium symbiosum) and a negatively associated network (37 species, including Roseburia and Lachnospira), forming a "seesaw-like" microbial association pattern characterized by within-group co-occurrence and between-group co-exclusion. The structures were stable across the independent datasets. A composite score derived from the microbial topology stratified CRN risk, and diagnostic models based solely on the presence/absence status of the topological species achieved moderate accuracy across the cohorts (area under the curve ranging from 0.66 to 0.87). Functionally, changes in CRN-related microbial association patterns were associated with microbe-derived metabolites. Our findings provide novel insights into the microbial topology associated with CRN and support its potential application in non-invasive risk stratification. However, the utility of these topological features in colorectal cancer remains exploratory and requires further validation in larger colorectal cancer cohorts.

Indexed as

colorectal neoplasiahuman gut microbiomemicrobiota‐derived metabolitesrisk stratificationtopologies

Identifiers

PMID42806489
PMCPMC13620265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.